|
Canada-0-TileNonCeramicDistributors 公司名錄
|
公司新聞:
- Amgen - A Worldwide Pioneer in Biotechnology
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics
- Discover Amgen and Search Our Jobs and Careers in Biotechnology
At Amgen, we are relentless in applying the highest ethical standards to our products, services and communications Consistent with this, we expect all job applicants to act with honesty and integrity Providing any false or misleading information, or omitting material information during the hiring process, may result in immediate disqualification from the hiring process or termination if
- Products | Amgen
Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options With a presence in approximately 100 countries, we are proud to have reached millions of people with our products
- 45 Years of Amgen
45 Years of Amgen How one of the first biotech companies grew into a global leader by taking on the world’s toughest diseases
- Contact Us - Amgen
Amgen Foundation For information about the Amgen Foundation, visit www AmgenFoundation org or follow us at @AmgenFoundation
- We Are Biotech | Amgen
Amgen helped establish the biotechnology industry more than 40 years ago and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and
- Amgen Worldwide
A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world
- Science | Amgen
Leveraging our deep understanding of biology, human and real-world data, we are moving science faster than ever before to find new and better ways to defeat the world's toughest diseases
- Amgen CEO Bob Bradways 2025 Letter to Shareholders
Amgen was founded in 1980, during the biotechnology revolution, with a simple but ambitious idea: harness the best of biology and technology to fight the world’s toughest diseases While the world and our industry have changed dramatically since then, our strategy has remained consistent over time We start with innovation, develop medicines that address serious diseases, and execute with
- AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE
Amgen expects to integrate Dark Blue Therapeutics into its existing research organization, further strengthening the company's early oncology discovery efforts About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases
|
|